Measuring Particle Size Distribution of Nanoparticle Enabled Medicinal Products, the Joint View of EUNCL and NCI-NCL. a Step By

Total Page:16

File Type:pdf, Size:1020Kb

Measuring Particle Size Distribution of Nanoparticle Enabled Medicinal Products, the Joint View of EUNCL and NCI-NCL. a Step By Journal of Controlled Release 299 (2019) 31–43 Contents lists available at ScienceDirect Journal of Controlled Release journal homepage: www.elsevier.com/locate/jconrel Review article Measuring particle size distribution of nanoparticle enabled medicinal T products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity ⁎ ⁎⁎ Caputo F.a, , Clogston J.b, Calzolai L.c, Rösslein M.d, Prina-Mello A.e,f, a Univ. Grenoble Alpes, CEA, LETI, F-38000 Grenoble, France b Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA c European Commission, Joint Research Centre, Via Enrico Fermi 2749, 21027 Ispra, VA, Italy d Swiss Federal Laboratories for Materials Research and Testing, Laboratory for Particles—Biology Interactions, EMPA, Lerchenfeldstrasse 5, St. Gallen CH-9014, Switzerland e Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Department of Clinical Medicine, Trinity Translational Medicine Institute (TTMI), School of Medicine, Trinity College Dublin, Dublin 8, Ireland f AMBER Centre and CRANN Institute, Trinity College Dublin, Dublin 2, Ireland ARTICLE INFO ABSTRACT Keywords: The particle size distribution (PSD) and the stability of nanoparticles enabled medicinal products (NEP) in complex Nanomedicine biological environments are key attributes to assess their quality, safety and efficacy. Despite its low resolution, Nanoparticles enabled medicinal products dynamic light scattering (DLS) is the most common sizing technique since the onset of NEP in pharmaceutical Physico-chemical properties technologies. Considering the limitations of the existing sizing measurements and the challenges posed by complex Particle size distribution NEPs both scientists and regulators encourage the combination of multiple orthogonal high-resolution approaches to Morphology shed light in the NEP sizing space (e.g. dynamic light scattering, electron microscopy, field flow fractionation coupled Standard operating procedures (SOPs) to online sizing detectors, centrifugal techniques, particle tracking analysis and tunable resistive pulse sensing). The pharmaceutical and biotechnology developers are now challenged to find their own pragmatic characterisation ap- proaches, which should be fit for purpose and minimize costs at the same time, in a complicated landscape whereonly a few standards exist. In order to support the community, the European Nanomedicine Characterisation Laboratory (EUNCL) and the US National Cancer Institute Nanotechnology Characterization Laboratory (NCI-NCL) have jointly developed multiple standard operating procedures (SOPs) for NEP assessment, including the measurements of particle size distribution, and are offering wide access to their ‘state of the art’ characterisation platforms, in additionto making SOPs publicly available. This joint perspective article would like to present the NCI-NCL and EUNCL multi- step approach of incremental complexity to measure particle size distribution and size stability of NEPs, consisting of a quick preliminary step to assess sample integrity and stability by low resolution techniques (pre-screening), followed by the combination of complementary high resolution sizing measurements performed both in simple buffers and in complex biological media. Test cases are presented to demonstrate: i) the need for employing at least one high- resolution sizing technique, ii) the importance of selecting the correct sizing techniques for the purpose, and iii) the robustness of utilizing orthogonal sizing techniques to study the physical properties of complex NEP samples. Abbreviations: AF4, asymmetric flow field flow fractionation; AUC, analytical ultracentrifugation; DCS, Differential centrifugal sedimentation; DLS, Dynamiclight scattering; EMA, European medical agency; EUNCL, European Nanomedicine Characterisation Laboratory; FDA, US Food and Drug Administration; FFF, field flow fractionation; MALS, multi angle light scattering; MNs, multinationals; NCI-NCL, National Cancer Institute Nanotechnology Characterization Lab; NEP, nanoparticle enabled medicinal products; NTA, nanoparticle tracking analysis; PCS, photon correlation spectroscopy; PdI, polydispersity index; PSD, particle size distribution; PTA, Particle tracking analysis; SEC, size exclusion chromatography; SMEs, small and medium enterprises; SOP, standard operating procedure; TEM, Transmission electron microscopy; TRPS, Tunable Resistive Pulse Sensing; UV, ultra-violet. ⁎ Corresponding author. ⁎⁎ Corresponding author at: Laboratory for Biological Characterisation of Advanced Materials (LBCAM), Department of Clinical Medicine, Trinity Translational Medicine Institute (TTMI), School of Medicine, Trinity College Dublin, Dublin 8, Ireland; AMBER Centre and CRANN Institute, Trinity College Dublin, Dublin 2, Ireland. E-mail addresses: [email protected], [email protected] (F. Caputo), [email protected] (A. Prina-Mello). https://doi.org/10.1016/j.jconrel.2019.02.030 Received 20 December 2018; Received in revised form 20 February 2019; Accepted 20 February 2019 Available online 21 February 2019 0168-3659/ © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/). F. Caputo, et al. Journal of Controlled Release 299 (2019) 31–43 1. Introduction addition, several articles are available where lessons learned and knowledge are shared with the scientific community [3–6,12,13]. The application of nanotechnology in healthcare has a tremendous From this close interaction, it emerged that average particle size, potential to address a variety of medical conditions by providing better particle size distribution (PSD) and aggregation behaviors in complex diagnostics and therapy. A broad range of nanoparticles enabled med- biological media are, among others, critical quality attributes for the icinal products (NEP) have been investigated for medical applications, preclinical characterisation of NEP [3,5,14–17]. In fact, they influence including liposomes, polymeric nanoparticles, lipid-based nano- the body absorption, biodistribution and excretion, during their phar- particles, micelles, nanocrystals, metal colloids, metal oxides, and many macological targeting and off targets effects [1,18,19]. Importantly, the others [1]. Unfortunately, when compared to the extensive research particle size and polydispersity can significantly change due to inter- activities in research laboratories and industries (e.g., SMEs and MNs), actions of plasma proteins with the NEP surface. In biological media the clinically approved nanomedicines are still very limited [2]. Among NEPs may aggregate increasing the average population size and even the extensive number of NEP published in literature, only about 50 sediment or, on the contrary, aggregation may be reduced, or they can candidates have successfully crossed the “valley of death”, and thus start to degrade, producing populations of smaller particles. translated from the research laboratories to scale up approved product Due to the key role in determining the efficacy and safety of NEP for use in clinical setups. Very often NEPs fail to reach late clinical [1], particle size, polydispersity and size stability should be controlled phases due to the lack of pre-clinical characterisation protocols, which in simple and in biological media from the early development stages, are needed to correlate their physico-chemical properties with their ideally from their design. At later stages, e.g. during routine manu- biological effects [1,3,4]. If compared to “classical” small molecule facturing, average size and polydispersity are key attributes to be drugs, the assessment of the quality, safety and efficacy profiles of NEPs controlled for quality purposes. According to the regulators' guidelines, demands the investigation of many additional physico-chemical prop- including EMA [8–10] and FDA [7,11], the NEP developers should not erties, including their chemical composition, average particle size and only characterise the particle size distribution of their products im- polydispersity, dispersion stability, particle shape, surface charge, drug mediately after their synthesis, but also study i) the reproducibility of loading and drug release, surface coating and hydrophobicity [1–3,5]. the manufacturing procedure (batch to batch consistency), ii) the long Moreover, the physico-chemical properties of NEP, including the size, term stability of the formulation during storage, iii) measure the na- physical and chemical stability, surface properties and drug release noparticle size in the final product administered to the patient andfi- profile, need to be investigated, not only in their original formulation, nally iv) analyze the changes of size and shape of the NEP after being in but also when dispersed in biological complex environments, since contact with physiological media (e.g., interactions with serum pro- different pH, high ionic strengths and the interactions with plasmacan teins) [3]. modify the physical properties of the particles, thus influencing their Many techniques are being used to measure the size distribution of safety and efficacy profiles [3,6,7]. To complicate matters even more, nanoparticle formulation in medicinal products, including electron the uniqueness of every NEP imposes a different methodological
Recommended publications
  • Dispersity in Polymer Science
    Pure Appl. Chem., Vol. 81, No. 2, pp. 351–353, 2009. doi:10.1351/PAC-REC-08-05-02 © 2009 IUPAC INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY POLYMER DIVISION SUBCOMMITTEE ON POLYMER TERMINOLOGY* DISPERSITY IN POLYMER SCIENCE (IUPAC Recommendations 2009) Prepared by a Working Group consisting of R. G. GILBERT (AUSTRALIA), M. HESS (GERMANY), A. D. JENKINS (UK), R. G. JONES (UK), P. KRATOCHVÍL (CZECH REPUBLIC), AND R. F. T. STEPTO (UK) Prepared for publication by R. F. T. STEPTO‡ Polymer Science and Technology Group, Manchester Materials Science Centre, School of Materials, The University of Manchester, Grosvenor Street, Manchester, M1 7HS, UK *Membership of the Subcommittee on Polymer Terminology† during the preparation of this report (2003–2008) was as follows: M. Barón (Argentina, Secretary until 2003); M. Hess (Germany, Chairman to 2005, Secretary, 2006–2007); R. G. Jones (UK, Secretary 2003–2005, Chairman, from 2006); T. Kitayama (Japan, Secretary, from 2008); G. Allegra (Italy); T. Chang (Korea); C. dos Santos (Brazil); A. Fradet (France); K. Hatada (Japan); J. He (China); K.-H. Hellwich (Germany); R. C. Hiorns (France); P. Hodge (UK); K. Horie (Japan); A. D. Jenkins (UK); J.-I. Jin (Korea); J. Kahovec (Czech Republic); P. Kratochvíl (Czech Republic); P. Kubisa (Poland); I. Meisel (Germany); W. V. Metanomski (USA); V. Meille (Italy); I. Mita (Japan); G. Moad (Australia); W. Mormann (Germany); C. Ober (USA); S. Penczek (Poland); L. P. Rebelo (Portugal); M. Rinaudo (France); I. Schopov (Bulgaria); M. Schubert (USA); F. Schué (France); V. P. Shibaev (Russia); S. Słomkowski (Poland); R. F. T. Stepto (UK); D. Tabak (Brazil); J.-P.
    [Show full text]
  • GPC - Gel Permeation Chromatography Aka Size Exclusion Chromatography- SEC
    GPC - Gel Permeation Chromatography aka Size Exclusion Chromatography- SEC Wendy Gavin Biomolecular Characterization Laboratory Version 1 May 2016 1 Table of Contents 1. GPC Introduction………………………………………………………. Page 3 2. How GPC works………………………………………………………... Page 5 3. GPC Systems…………………………………………………………… Page 7 4. GPC/SEC Separations – Theory and System Considerations… Page 9 5. GPC Reports……………………………………………………………. Page 10 6. Calibrations of GPC systems………………………………………... Page 14 7. GPC preparation……………………………………………………….. Page 16 8. Alliance System………………………………………………………… Page 17 9. GPC columns…………………………………………………………… Page 18 2 1. GPC Introduction Gel permeation chromatography (GPC) is one of the most powerful and versatile analytical techniques available for understanding and predicting polymer performance. It is the most convenient technique for characterizing the complete molecular weight distribution of a polymer. Why is GPC important? GPC can determine several important parameters. These include number average molecular weight (Mn), weight average molecular weight(Mw) Z weight average molecular weight(Mz), and the most fundamental characteristic of a polymer its molecular weight distribution(PDI) These values are important, since they affect many of the characteristic physical properties of a polymer. Subtle batch-to-batch differences in these measurable values can cause significant differences in the end-use properties of a polymer. Some of these properties include: Tensile strength Adhesive strength Hardness Elastomer relaxation Adhesive tack Stress-crack resistance Brittleness Elastic modules Cure time Flex life Melt viscosity Impact strength Tear Strength Toughness Softening temperature 3 Telling good from bad Two samples of the same polymer resin can have identical tensile strengths and melt viscosities, and yet differ markedly in their ability to be fabricated into usable, durable products.
    [Show full text]
  • Lecture Notes on Structure and Properties of Engineering Polymers
    Structure and Properties of Engineering Polymers Lecture: Microstructures in Polymers Nikolai V. Priezjev Textbook: Plastics: Materials and Processing (Third Edition), by A. Brent Young (Pearson, NJ, 2006). Microstructures in Polymers • Gas, liquid, and solid phases, crystalline vs. amorphous structure, viscosity • Thermal expansion and heat distortion temperature • Glass transition temperature, melting temperature, crystallization • Polymer degradation, aging phenomena • Molecular weight distribution, polydispersity index, degree of polymerization • Effects of molecular weight, dispersity, branching on mechanical properties • Melt index, shape (steric) effects Reading: Chapter 3 of Plastics: Materials and Processing by A. Brent Strong https://www.slideshare.net/NikolaiPriezjev Gas, Liquid and Solid Phases At room temperature Increasing density Solid or liquid? Pitch Drop Experiment Pitch (derivative of tar) at room T feels like solid and can be shattered by a hammer. But, the longest experiment shows that it flows! In 1927, Professor Parnell at UQ heated a sample of pitch and poured it into a glass funnel with a sealed stem. Three years were allowed for the pitch to settle, and in 1930 the sealed stem was cut. From that date on the pitch has slowly dripped out of the funnel, with seven drops falling between 1930 and 1988, at an average of one drop every eight years. However, the eight drop in 2000 and the ninth drop in 2014 both took about 13 years to fall. It turns out to be about 100 billion times more viscous than water! Pitch, before and after being hit with a hammer. http://smp.uq.edu.au/content/pitch-drop-experiment Liquid phases: polymer melt vs.
    [Show full text]
  • Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
    pharmaceutics Review Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems M. Danaei, M. Dehghankhold, S. Ataei, F. Hasanzadeh Davarani, R. Javanmard, A. Dokhani, S. Khorasani and M. R. Mozafari * ID Australasian Nanoscience and Nanotechnology Initiative, 8054 Monash University LPO, Clayton, Victoria 3168, Australia; [email protected] (M.Da.); [email protected] (M.De.); [email protected] (S.A.); [email protected] (F.H.D.); [email protected] (R.J.); [email protected] (A.D.); [email protected] (S.K.) * Correspondence: [email protected]; Tel.: +61-42433-9961 Received: 14 April 2018; Accepted: 17 May 2018; Published: 18 May 2018 Abstract: Lipid-based drug delivery systems, or lipidic carriers, are being extensively employed to enhance the bioavailability of poorly-soluble drugs. They have the ability to incorporate both lipophilic and hydrophilic molecules and protecting them against degradation in vitro and in vivo. There is a number of physical attributes of lipid-based nanocarriers that determine their safety, stability, efficacy, as well as their in vitro and in vivo behaviour. These include average particle size/diameter and the polydispersity index (PDI), which is an indication of their quality with respect to the size distribution. The suitability of nanocarrier formulations for a particular route of drug administration depends on their average diameter, PDI and size stability, among other parameters. Controlling and validating these parameters are of key importance for the effective clinical applications of nanocarrier formulations. This review highlights the significance of size and PDI in the successful design, formulation and development of nanosystems for pharmaceutical, nutraceutical and other applications.
    [Show full text]
  • Size-Exclusion Chromatography and Its Optimization for Material Science
    cien al S ce Netopilík and Trhlíková, J Material Sci Eng 2017, 6:4 ri s te & a E M n DOI: 10.4172/2169-0022.1000358 f g o i n l e a e n r r i n u g o Journal of Material Sciences & Engineering J ISSN: 2169-0022 Research Article Article Open Access Size-Exclusion Chromatography and Its Optimization for Material Science Netopilík M* and Trhlíková O Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic Abstract A theoretical analysis of improving the separation power of size exclusion chromatography by decreasing flow- rate is conveyed. The variance of the elution curves is larger than expected form estimated dispersity in molecular weight, Mw/Mn. The shape of the elution curves depends strongly on experimental conditions. When the experimental conditions are approaching those to the ideal separation, judged by statistical properties of the curves, both skew and excess kurtosis of the elution curves increase near the exclusion limit in accord with theoretical prediction. In analyses of polystyrene standards by size exclusion chromatography for polymers of molecular weight about thirty thousand and higher, the longitudinal diffusion is not important even at low flow-rates. Keywords: Separation mechanism; Size-exclusion chromatography; In the theory of chromatographic separation and band broadening, Band broadening function; Skew; Excess kurtosis BBF is called the elution curve of an analyte uniform in molecular weight and chemical composition [15]. For its description, several Introduction mathematical models of separation were developed. The kinetic model The material science has ever been the driving force of the progress by Giddings and Eyring assumes that the capture of molecules of the which has always advanced with the progress in analytical sciences.
    [Show full text]
  • Catalyst Moatsou, D.; O'reilly, R.K
    University of Birmingham Catalyst Moatsou, D.; O'Reilly, R.K. DOI: 10.1016/j.chempr.2019.02.017 License: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) Document Version Peer reviewed version Citation for published version (Harvard): Moatsou, D & O'Reilly, RK 2019, 'Catalyst: size distribution in self-assembly matters', Chem, vol. 5, no. 3, pp. 487-490. https://doi.org/10.1016/j.chempr.2019.02.017 Link to publication on Research at Birmingham portal General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. •Users may freely distribute the URL that is used to identify this publication. •Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private study or non-commercial research. •User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?) •Users may not further distribute the material nor use it for the purposes of commercial gain. Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document. When citing, please reference the published version. Take down policy While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been uploaded in error or has been deemed to be commercially or otherwise sensitive.
    [Show full text]
  • Nucleation Control in Size and Dispersity in Metallic Nanoparticles: the Rp Ominent Role of Particle Aggregation Vernal Richards Washington University in St
    Washington University in St. Louis Washington University Open Scholarship All Theses and Dissertations (ETDs) January 2010 Nucleation Control in Size and Dispersity in Metallic Nanoparticles: The rP ominent Role of Particle Aggregation Vernal Richards Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/etd Recommended Citation Richards, Vernal, "Nucleation Control in Size and Dispersity in Metallic Nanoparticles: The rP ominent Role of Particle Aggregation" (2010). All Theses and Dissertations (ETDs). 294. https://openscholarship.wustl.edu/etd/294 This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Department of Chemistry Dissertation Examination Committee: William E. Buhro, Chair Daniel E. Giammar Patrick C. Gibbons Sophia E. Hayes Richard A. Loomis Jacob Schaefer Nucleation Control In Size and Dispersity of Metallic Nanoparticles: The Prominent Role of Particle Aggregation by Vernal N. Richards A dissertation presented to the Graduate School of Arts and Sciences of Washington University in St. Louis in partial fulfillment of the requirements for the degree of Doctor of Philosophy August 2010 Saint Louis, Missouri ABSTRACT OF THE DISSERTATION Nucleation Control In Size and Dispersity of Metallic Nanoparticles: The Prominent Role of Particle Aggregation by Vernal N. Richards Doctor of Philosophy in Chemistry Washington University in St Louis, 2010 Professor William E. Buhro, Chair The aim of this project is to investigate the effect of aggregative nucleation and growth on the final size and dispersity in metallic nanoparticle systems.
    [Show full text]
  • Effect of Chain End Functional and Chain Architecture On
    EFFECT OF CHAIN END FUNCTIONAL AND CHAIN ARCHITECTURE ON SURFACE SEGREGATION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Zimo Zhang June, 2017 EFFECT OF CHAIN END FUNCTIONAL AND CHAIN ARCHITECTURE ON SURFACE SEGREGATION Zimo Zhang Thesis Approved: Accepted: ______________________________ ______________________________ Advisor Dean of the College Dr. Mark D. Foster Dr. Eric J. Amis ______________________________ ______________________________ Faculty Reader Dean of the Graduate School Dr. Li Jia Dr. Chand Midha ______________________________ ______________________________ Department Chair Date Dr. Coleen Pugh i ABSTRACT The objective of the research was to study the effects on surface segregation in binary polymer blends of both chain end functionalization of linear chains, and changes in architecture. An important question for the formation and application of a polymer thin film is the degree to which end group functionalization can influence the segregation of a chain to the air/polymer and polymer/substrate interfaces. For the first part of this study, well-defined polystyrene and hydroxyethylated functionalized polystyrene of exactly the same molecular weight (Mn = 6000 g/mol) were synthesized using anionic polymerization in order to minimize the impact of factors other than end group functionalization in the study of the segregation driven by the functionalization. Thin (90 nm) films of blends of these two chains spun cast on silicon substrates were investigated. Key to the study was use of a new method called Surface Layer Matrix Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (SL-MALDI-TOF-MS) which determines the composition at the surface (< 2 nm depth) of entire polymer chains, rather than the segment or chain end composition measured with other techniques.
    [Show full text]
  • 3D Printing) of Graphene-Based Ceramic Nanocomposites: a Review
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 23 April 2020 doi:10.20944/preprints202004.0409.v1 Review Direct Ink Writing Technology (3D Printing) of Graphene-Based Ceramic Nanocomposites: A Review Nestor Washington Solís Pinargote*, Anton Smirnov*, Nikita Peretyagin, Anton Seleznev and Pavel Peretyagin Moscow State University of Technology “STANKIN”, Vadkovsky per. 1, Moscow, 127055, Russian Federation; [email protected] (N.P.); [email protected] (A.S.); [email protected] (P.P.) * Correspondence: [email protected] (N.W.S.P.); [email protected] (A.S.); Tel.: +7-4999-7323-70 (N.W.S.P.) and (A.S.) Abstract: In the present work, the state of the art of the most common additive manufacturing (AM) technologies used for the manufacturing of complex shape structures of graphene-based ceramic nanocomposites, ceramic and graphene-based parts is explained. A brief overview of the AM processes for ceramic, which are grouped by the type of feedstock used in each technology, is presented. The main technical factors that affect the quality of the final product were reviewed. The AM processes used for 3D printing of graphene-based materials are described in more detail; moreover, some studies in a wide range of applications related to these AM techniques are cited. Furthermore, different feedstock formulations and their corresponding rheological behaviour were explained. Additionally, the most important works about the fabrication of composites using graphene-based ceramic pastes by Direct Ink Writing (DIW) are disclosed in detail and illustrated with representative examples. Various examples of the most relevant approaches for the manufacturing of graphene-based ceramic nanocomposites by DIW are provided.
    [Show full text]
  • Gel Permeation Chromatography and Size Exclusion Chromatography
    An Introduction to Gel Permeation Chromatography and Size Exclusion Chromatography PRIMER Contents Start here 3 Chapter 4 – GPC/SEC in action; A note on names 3 real world applications 18 Seven things you should know about GPC/SEC 3 Gum arabic, good and bad 18 Chapter 1 – What is chromatography? 4 Fingerprinting nail varnish 18 Types of chromatography 4 Modifying PVC 19 Gas chromatography 4 Chapter 5 – FAQs 20 High performance liquid chromatography 5 Appendix 21 Gel permeation/size exclusion chromatography 5 Recommendations for Chapter 2 – GPC/SEC overview 6 setting up a GPC/SEC system 21 Polymers 6 Choosing an eluent for GPC/SEC 21 Size matters 6 Choosing a column for GPC/SEC 21 How does GPC/SEC work 7 Setting up the GPC/SEC system 22 Who uses GPC/SEC, what for and why 8 What standards should I use? 22 Calibrations 8 Typical polymer molecular weights 23 Calculations in GPC/SEC 9 Ordering Information 24 Types of polymer distribution 11 Agilent solutions for GPC/SEC 27 Chapter 3 – GPC/SEC in practice 13 Glossary and abbreviations 28 Solvents and solvent containers 13 Suggestions for further reading 30 Ovens 13 Samples 14 Injection and injectors 14 Columns and column sets 14 Pumps 15 Detectors 16 Conventional GPC/SEC 17 Multi-detector GPC/SEC 17 Automatic data processing 17 35 years’ expertise in GPC/SEC 1990 PL aquagel-OH columns 1981 PLgel MIXED columns, Vastly improve resolution and data quality PL aquagel columns in aqueous GPC MIXED columns improve data quality, with novel chemistries for analysis of water soluble polymers 1984 GPC software 1976 PLgel columns, individual Dedicated software streamlines standards and standard kits GPC/SEC calculations Polymer Laboratories founded to develop market leading products for organic GPC/SEC 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 1900s 2 Start here This guide provides some background to the most common Seven things you should know about GPC/SEC techniques and applications of gel permeation chromatography, 1.
    [Show full text]
  • Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
    molecules Review Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology Aleksandra Zieli ´nska 1,2 , Filipa Carreiró 1, Ana M. Oliveira 1, Andreia Neves 1,Bárbara Pires 1, D. Nagasamy Venkatesh 3 , Alessandra Durazzo 4 , Massimo Lucarini 4, Piotr Eder 5 , Amélia M. Silva 6,7 , Antonello Santini 8,* and Eliana B. Souto 1,9,* 1 Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; [email protected] (A.Z.); fi[email protected] (F.C.); [email protected] (A.M.O.); [email protected] (A.N.); [email protected] (B.P.) 2 Institute of Human Genetics, Polish Academy of Sciences, Strzeszy´nska32, 60-479 Pozna´n,Poland 3 JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty 643 001, Tamil Nadu, India; nagasamyvenkatesh@rediffmail.com 4 CREA-Research Centre for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy; [email protected] (A.D.); [email protected] (M.L.) 5 Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Przybyszewskiego 49, 60–355 Pozna´n,Poland; [email protected] 6 Department of Biology and Environment, University of Tras-os-Montes e Alto Douro, UTAD, Quinta de Prados, 5001-801 Vila Real, Portugal; [email protected] 7 Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB-UTAD), Quinta de Prados, 5001-801 Vila Real, Portugal 8
    [Show full text]
  • Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering
    Kaasalainen et al. Nanoscale Research Letters (2017) 12:74 DOI 10.1186/s11671-017-1853-y NANOEXPRESS Open Access Size, Stability, and Porosity of Mesoporous Nanoparticles Characterized with Light Scattering Martti Kaasalainen1*, Vladimir Aseyev2, Eva von Haartman3, Didem Şen Karaman3, Ermei Mäkilä1, Heikki Tenhu2, Jessica Rosenholm3 and Jarno Salonen1* Abstract Silicon-based mesoporous nanoparticles have been extensively studied to meet the challenges in the drug delivery. Functionality of these nanoparticles depends on their properties which are often changing as a function of particle size and surrounding medium. Widely used characterization methods, dynamic light scattering (DLS), and transmission electron microscope (TEM) have both their weaknesses. We hypothesize that conventional light scattering (LS) methods can be used for a rigorous characterization of medium sensitive nanoparticles’ properties, like size, stability, and porosity. Two fundamentally different silicon-based nanoparticles were made: porous silicon (PSi) from crystalline silicon and silica nanoparticles (SN) through sol-gel process. We studied the properties of these mesoporous nanoparticles with two different multiangle LS techniques, DLS and static light scattering (SLS), and compared the results to dry-state techniques, TEM, and nitrogen sorption. Comparison of particle radius from TEM and DLS revealed significant overestimation of the DLS result. Regarding to silica nanoparticles, the overestimation was attributed to agglomeration by analyzing radius of gyration and hydrodynamic radius. In case of PSi nanoparticles, strong correlation between LS result and specific surface area was found. Our results suggest that the multiangle LS methods could be used for the size, stability, and structure characterization of mesoporous nanoparticles. Keywords: Porosity, Porous silicon, Mesoporous silica nanoparticle, Light scattering, Particle size, Biorelevant characterization Background surface area [10].
    [Show full text]